Concepedia

Author

Annerie Slot

Radiotherapeutisch Instituut FrieslandORCID

Also Known As

A Slot, A. Bruins Slot, A. J. M. Slot, A. Slot, A.S. Bruins Slot, Alexandra Bruins Slot, Annerie Slot, J. W. M. Mens, J.H. Tabak

77

Publications

9.2K

Citations

29

H-Index

33

Concepts

All Affiliations

Radiotherapeutisch Instituut FrieslandLeiden University Medical CenterThe Netherlands Cancer InstituteRadboud University NijmegenUniversity Medical Center Groningen
AS

About

Annerie Slot is an author at Radiotherapeutisch Instituut Friesland specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

5.3K

2

Health Sciences

8

8

992

3

Obstetrics

5

5

1.7K

4

Gastroenterology

2

2

575

5

Orthopaedics

1

1

18

Annerie Slot

×

33

Publications

8.8K

Citations

28

H-Index

YearCitations

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten,

The Lancet Oncology

2020

1.5K

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Hein Putter, IM Jürgenliemk-Schulz, JJ Jobsen,

The Lancet

2010

1.1K

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper,

Journal of Clinical Oncology

2006

971

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin,

The Lancet Oncology

2018

599

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken,

The Lancet Oncology

2018

562

Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, Wim L.J. van Putten,

International Journal of Radiation Oncology*Biology*Physics

2005

442

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin,

The Lancet Oncology

2019

432

Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer

Abrahim Al‐Mamgani, Wim L.J. van Putten, Wilma D. Heemsbergen,

International Journal of Radiation Oncology*Biology*Physics

2008

416

Outcome of High-Risk Stage IC, Grade 3, Compared With Stage I Endometrial Carcinoma Patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial

Carien L. Creutzberg, Wim L.J. van Putten, Carla C. Wárlám-Rodenhuis,

Journal of Clinical Oncology

2004

277

Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial

Remi A. Nout, Hein Putter, Ina M. Jürgenliemk‐Schulz,

Journal of Clinical Oncology

2009

269

Page 1